Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- Obstructive Hypertrophic Cardiomyopathy”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Testing effectiveness (Phase 2)Study completedNCT02842242
What this trial is testing

Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Who this might be right for
Cardiomyopathy, Hypertrophic ObstructiveLeft Ventricular Outflow Tract Obstruction
MyoKardia, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00001894
What this trial is testing

A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI) 70
Large-scale testing (Phase 3)Looking for participantsNCT06412666
What this trial is testing

Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Who this might be right for
PediatricSymptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics 55
Not applicableStudy completedNCT01729702
What this trial is testing

Neurohormonal Parameters in Hypertrophic Cardiomyopathies

Who this might be right for
1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy2- Obstructive Hypertrophic Cardiomyopathy3- Non Obstructive Hypertrophic Cardiomyopathy
French Cardiology Society 131
Testing effectiveness (Phase 2)Study completedNCT03442764
What this trial is testing

Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
MyoKardia, Inc. 59
Large-scale testing (Phase 3)Ended earlyNCT02291237
What this trial is testing

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Gilead Sciences 172
Testing effectiveness (Phase 2)Looking for participantsNCT07367724
What this trial is testing

Ademetionine in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
China National Center for Cardiovascular Diseases 44
Not applicableUnknownNCT02917395
What this trial is testing

Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients

Who this might be right for
Cardiomyopathy
Rabin Medical Center 50